These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9148148)

  • 1. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery.
    Reis SE; Feldman AH
    N Engl J Med; 1997 May; 336(20):1453; author reply 1453-4. PubMed ID: 9148148
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery.
    Petros JA
    N Engl J Med; 1997 May; 336(20):1452; author reply 1453-4. PubMed ID: 9148146
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery.
    Devereaux PJ; Ghali WA
    N Engl J Med; 1997 May; 336(20):1452-3; author reply 1453-4. PubMed ID: 9148147
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group.
    Mangano DT; Layug EL; Wallace A; Tateo I
    N Engl J Med; 1996 Dec; 335(23):1713-20. PubMed ID: 8929262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery.
    Ho T; Taussig D; McAnulty G
    N Engl J Med; 1997 May; 336(20):1452; author reply 1453-4. PubMed ID: 9148145
    [No Abstract]   [Full Text] [Related]  

  • 6. Reducing cardiovascular risk in patients undergoing noncardiac surgery.
    Eagle KA; Froehlich JB
    N Engl J Med; 1996 Dec; 335(23):1761-3. PubMed ID: 8929270
    [No Abstract]   [Full Text] [Related]  

  • 7. [Still uncertainty about the usefulness of perioperative beta-blockade. Conclusive studies concerning patients with cardiovascular risk factors not available].
    Gannedahl P
    Lakartidningen; 2006 Sep 13-19; 103(37):2638-40, 2643. PubMed ID: 17022183
    [No Abstract]   [Full Text] [Related]  

  • 8. Atenolol for prevention of postsurgical cardiovascular events.
    Shapley-Quinn K; Newton W
    J Fam Pract; 1997 Mar; 44(3):243, 247. PubMed ID: 9071238
    [No Abstract]   [Full Text] [Related]  

  • 9. Quo vadis, perioperative beta blockade? Are you "POISE'd" on the brink?
    London MJ
    Anesth Analg; 2008 Apr; 106(4):1025-30. PubMed ID: 18349169
    [No Abstract]   [Full Text] [Related]  

  • 10. Does tight heart rate control improve beta-blocker efficacy? An updated analysis of the noncardiac surgical randomized trials.
    Beattie WS; Wijeysundera DN; Karkouti K; McCluskey S; Tait G
    Anesth Analg; 2008 Apr; 106(4):1039-48, table of contents. PubMed ID: 18349171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Con: Beta-blockers are indicated for all adults at increased risk undergoing noncardiac surgery.
    London MJ
    Anesth Analg; 2007 Jan; 104(1):11-4. PubMed ID: 17179238
    [No Abstract]   [Full Text] [Related]  

  • 12. When heart patients need non-heart operations.
    Johns Hopkins Med Lett Health After 50; 1999 Jun; 11(4):3. PubMed ID: 10377900
    [No Abstract]   [Full Text] [Related]  

  • 13. [The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with diabetes mellitus in the LIFE-study].
    Ibsen H; Lindholm LH; Pedersen OL; Dahlöf B; Kjeldsen S
    Ugeskr Laeger; 2003 Jan; 165(5):459-62. PubMed ID: 12599844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-blocker therapy in noncardiac surgery.
    Poldermans D; Boersma E
    N Engl J Med; 2005 Jul; 353(4):412-4. PubMed ID: 16049214
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension and ECG-verified left ventricular hypertrophy in the LIFE-study].
    Ibsen H; Pedersen OL; Dahlöf B; Kjeldsen SE; Lindholm LH
    Ugeskr Laeger; 2003 Jan; 165(5):456-9. PubMed ID: 12599843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Diabetic Postoperative Mortality and Morbidity (DIPOM) trial: rationale and design of a multicenter, randomized, placebo-controlled, clinical trial of metoprolol for patients with diabetes mellitus who are undergoing major noncardiac surgery.
    Juul AB; Wetterslev J; Kofoed-Enevoldsen A; Callesen T; Jensen G; Gluud C;
    Am Heart J; 2004 Apr; 147(4):677-83. PubMed ID: 15077084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of beta-blockade to prevent death after noncardiac surgery.
    Wallace A; Mangano DT
    West J Med; 1997 Mar; 166(3):203-4. PubMed ID: 9143199
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.
    Wachtell K; Hornestam B; Lehto M; Slotwiner DJ; Gerdts E; Olsen MH; Aurup P; Dahlöf B; Ibsen H; Julius S; Kjeldsen SE; Lindholm LH; Nieminen MS; Rokkedal J; Devereux RB
    J Am Coll Cardiol; 2005 Mar; 45(5):705-11. PubMed ID: 15734614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A population-based analysis of the class effect of beta-blockers after myocardial infarction.
    Rinfret S; Abrahamowicz M; Tu J; Humphries K; Eisenberg MJ; Richard H; Austin PC; Pilote L
    Am Heart J; 2007 Feb; 153(2):224-30. PubMed ID: 17239680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Atenolol or metoprolol as beta-blocker in the treatment of hypertension].
    van den Born BJ; Brewster LM; Koopmans RP; van Montfrans GA
    Ned Tijdschr Geneeskd; 2005 Aug; 149(32):1808-9. PubMed ID: 16121668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.